Drug intelligence / Profile preview

AuNPs + Pc158

Development stage
Preclinical
Modality
Nanoparticles → Drug Delivery Systems, Small Molecules
01

Overview

AuNPs + Pc158 is an experimental **PSMA-targeted, cathepsin-activatable gold nanoparticle photodynamic theranostic** being studied for prostate cancer imaging and treatment. The construct comprises PEGylated gold nanoparticles conjugated to the silicon phthalocyanine photosensitizer **Pc158**, an analogue of Pc4, through a cathepsin-cleavable **GLFGC** linker. In this design, the gold nanoparticle functions as both a delivery vehicle and quencher; after accumulation in PSMA-expressing tumor tissue and proteolytic cleavage in the tumor microenvironment, Pc158 is released or dequenched, enabling fluorescence imaging and restoration of photodynamic activity upon near-infrared light exposure. The program appears to be preclinical and has been evaluated in translational prostate cancer models, including canine prostate cancer, as a precision imaging and therapy approach.

Other names
gold nanoparticles + Pc158PSMA-targeted gold nanoparticles + Pc158PSMA-targeted cathepsin-activatable AuNPs + Pc158
02

Targets

PSMA (Prostate-specific membrane antigen)CTS (Cathepsin family)

Beyond the preview

Go deeper on AuNPs + Pc158.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AuNPs + Pc158.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call